Macrolide-Resistant Mycoplasma Pneumoniae Infections Among Children After COVID-19 Pandemic, Ohio, USA
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
Mycoplasma pneumoniae infections decreased in Ohio, USA, during the COVID-19 pandemic but reemerged in 2023; >2,000 cases were reported during September 2023--September 2024. Of 995 M. pneumoniae-positive samples, 24 (2.4%) had mutations for macrolide-resistant M. pneumoniae (MRMp). MRMp rates are low but increasing. MRMp surveillance is crucial for monitoring antimicrobial resistance.
References
1.
Kim K, Jung S, Kim M, Park S, Yang H, Lee E
. Global Trends in the Proportion of Macrolide-Resistant Mycoplasma pneumoniae Infections: A Systematic Review and Meta-analysis. JAMA Netw Open. 2022; 5(7):e2220949.
PMC: 9274321.
DOI: 10.1001/jamanetworkopen.2022.20949.
View
2.
Meyer Sauteur P, Beeton M, Uldum S, Bossuyt N, Vermeulen M, Loens K
. detections before and during the COVID-19 pandemic: results of a global survey, 2017 to 2021. Euro Surveill. 2022; 27(19).
PMC: 9101966.
DOI: 10.2807/1560-7917.ES.2022.27.19.2100746.
View
3.
Leber A, Oyeniran S, Wang H
. Reduced sensitivity of a multiplex commercial respiratory panel for detection of is due to specimen type. J Clin Microbiol. 2024; 62(10):e0113924.
PMC: 11481544.
DOI: 10.1128/jcm.01139-24.
View
4.
Dumke R
. The high-incidence period of Mycoplasma pneumoniae infections 2023/2024 in southeast Germany was associated with a low level of macrolide resistance. Infection. 2024; 52(6):2525-2527.
PMC: 11621181.
DOI: 10.1007/s15010-024-02336-4.
View
5.
Lanata M, Wang H, Everhart K, Moore-Clingenpeel M, Ramilo O, Leber A
. Macrolide-Resistant Mycoplasma pneumoniae Infections in Children, Ohio, USA. Emerg Infect Dis. 2021; 27(6):1588-1597.
PMC: 8153876.
DOI: 10.3201/eid2706.203206.
View